LOGIN  |  REGISTER
Terns Pharmaceuticals
Recursion

Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15

March 08, 2023 | Last Trade: US$0.07 0.0003 -0.41

ANN ARBOR, MI / ACCESSWIRE / March 8, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Wednesday, March 15, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its fourth quarter and fiscal year ended December 31, 2022. A question-and-answer session will follow management's prepared remarks.

Event:Zomedica Q4 and Fiscal Year 2022 Financial Results Conference Call
Date:Wednesday, March 15, 2023
Time:4:30 p.m. Eastern Time
Live Call:+1-877-407-0789 (U.S. Toll-Free) or +1-201-689-8562 (International)
Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1601606&tp_key=1c4e47625b

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until March 29, 2023 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 13736703.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica's mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.

Follow Zomedica

Email Alerts: http://investors.zomedica.com

LinkedIn: https://www.linkedin.com/company/zomedica

Facebook: https://m.facebook.com/zomedica

Twitter: https://twitter.com/zomedica

Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact:

RedChip Companies Inc.
Barrett Boone
This email address is being protected from spambots. You need JavaScript enabled to view it.
407-571-0912

Assertio

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page